AbbVie
ABBV
#24
Rank
A$602.90 B
Marketcap
$341.52
Share price
-0.93%
Change (1 day)
25.95%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of March 2025 (TTM): 6.79

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 114. At the end of 2024 the company had a P/S ratio of 5.58.

P/S ratio history for AbbVie from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.5810.86%
20235.042.32%
20224.9215.58%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.51-63.01%๐Ÿ‡บ๐Ÿ‡ธ USA
2.65-60.95%๐Ÿ‡บ๐Ÿ‡ธ USA
16.5 143.70%๐Ÿ‡บ๐Ÿ‡ธ USA
5.26-22.51%๐Ÿ‡บ๐Ÿ‡ธ USA
5.16-24.03%๐Ÿ‡บ๐Ÿ‡ธ USA
2.28-66.42%๐Ÿ‡บ๐Ÿ‡ธ USA
2.04-69.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.46-34.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.69-30.87%๐Ÿ‡บ๐Ÿ‡ธ USA